Skip to main content

Global Cannabidiol (CBD) Market: The Rise of CBD Products and the 16% CAGR Growth Forecast Through 2030

 


The global cannabidiol (CBD) market is set to witness a growth rate of 16% in the next 5 years. Increasing consumer awareness and acceptance of CBD’s potential therapeutic benefits; expanding applications of CBD in healthcare and wellness; growing legalization of cannabis and CBD products; and increasing investment and product innovation efforts are some of the key factors driving the cannabidiol market. 

Cannabidiol (CBD) is a natural compound found in Cannabis sativa plants, including hemp and marijuana. Unlike tetrahydrocannabinol (THC), CBD is non-psychoactive, and is primarily known for its potential therapeutic effects. CBD interacts with the body’s endocannabinoid system, which regulates processes like pain, mood, and immune response. Known for its potential therapeutic effects, CBD is widely used to alleviate anxiety, pain, and inflammation, and it’s incorporated into various products, including oils, edibles, creams, and supplements. Its popularity is rising due to its perceived health benefits, though research is ongoing, and regulatory status varies across countries and regions.

🔗 Want deeper insights? Download the sample report:

https://meditechinsights.com/cannabidiol-market/request-sample/

Increasing consumer awareness and acceptance of CBD’s potential therapeutic benefits to propel market demand

Increasing consumer awareness and acceptance of CBD's potential therapeutic benefits is a key driver in the cannabidiol market. As studies and testimonials highlight CBD’s ability to alleviate issues like anxiety, chronic pain, and inflammation, consumers are increasingly open to trying CBD products. Additionally, the perception of CBD as a natural, non-psychoactive remedy distinguishes it from THC, appealing to health-conscious and wellness-oriented consumers. CBD’s incorporation into various products, such as oils, edibles, cosmetics, and supplements, further broadens its reach. This growing acceptance, combined with product diversity, is accelerating market growth and expanding CBD’s consumer base worldwide.

Growing legalization of cannabis and CBD products is driving the market growth

The growing legalization of cannabis and CBD products is significantly driving the cannabidiol market by opening up regulated pathways for production, distribution, and consumption. In regions like the US, Canada, and parts of Europe, legal reforms have increased CBD’s accessibility, enabling businesses to operate transparently and expand offerings across wellness, healthcare, and personal care. Legalization also boosts consumer confidence, as regulated products undergo quality and safety testing. Furthermore, emerging markets in Latin America and Asia-Pacific are following suit, creating new growth opportunities for CBD companies. This global shift in policy fosters market expansion and supports innovation in CBD products.

Competitive Landscape Analysis

The global cannabidiol market is marked by the presence of established and emerging market players such as Medical Marijuana, Inc., Canopy Growth Corporation, PharmaHemp, ENDOCA, Folium Europe B.V., Isodiol International Inc., Gaia Botanics, NuLeaf Naturals, LLC, Elixinol, and Joy Organics; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Gain a competitive edge-request a sample report now! 

https://meditechinsights.com/cannabidiol-market/request-sample/

Global Cannabidiol Market Segmentation

This report by Medi-Tech Insights provides the size of the global cannabidiol market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, application, source, and distribution channel.

  • Market Size & Forecast (2023-2030), By Product, USD Million
    • Oils and Tinctures
    • Edibles
    • Edibles
    • Capsules and Soft gels
    • Topicals
    • Others
  • Market Size & Forecast (2023-2030), By Application, USD Million
    • Medical and Pharmaceutical Applications
      • Pain Management
      • Mental Disorders
      • Neurological Disorders
      • Cancer
      • Other Medical Applications
    • Wellness and Personal Care
    • Food and Beverages
    • Nutraceuticals
    • Veterinary Care
    • Others
  • Market Size & Forecast (2023-2030), By Source, USD Million
    • Hemp-Derived
    • Marijuana-Derived
  • Market Size & Forecast (2023-2030), By Distribution Channel, USD Million
    • Online Retail
    • Pharmacies
    • Specialty Stores
    • Convenience Stores and Supermarkets
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...
Post a Comment
Read more